FDA May Extend NDA Pathway to Increase Access to Nonprescription Drugs

The FDA proposes to extend the new drug application pathway to include therapeutic indications that have not previously been available for nonprescription drugs, Commissioner Scott Gottlieb said on Tuesday in announcing a new draft guidance on the initiative.
Source: Drug Industry Daily